Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 8.92% is 76% above its 5-year average of 5.06%, around the middle of its 5-year range (2.39%–13.58%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.59% above its 12-month average of 8.78%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.92%.
DEBT TO ASSETS RATIO
8.92%
DEBT TO ASSETS RATIO AVG TTM
8.78%
DEBT TO ASSETS RATIO AVG 3Y
6.08%
DEBT TO ASSETS RATIO AVG 5Y
5.06%
DEBT TO ASSETS RATIO AVG 10Y
8.82%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+1.59%
CURRENT VS 3Y AVG
+46.60%
CURRENT VS 5Y AVG
+76.28%
CURRENT VS 10Y AVG
+1.07%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 597 covered companies
CURRENT VS SECTOR MEDIAN
+8815.53%
vs the sector median at left
Insight Molecular Diagnostics Inc.
Market Cap
$116.57M
Debt to Assets Ratio
8.92%
TTM Avg
8.78%
3Y Avg
6.08%
5Y Avg
5.06%
Market Cap
$116.54M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$116.83M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$114.79M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$120.24M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$112.52M
Debt to Assets Ratio
0.64%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$112.36M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$121.25M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | $116.57M | 8.92% | 8.78% | 6.08% | 5.06% |
| Caribou Biosciences, Inc. (CRBU)vs › | $116.54M | 0.19% | N/A | N/A | N/A |
| LENZ Therapeutics, Inc. (LENZ)vs › | $116.83M | 0.00% | N/A | N/A | N/A |
| Genelux Corporation (GNLX)vs › | $114.79M | 0.09% | N/A | N/A | N/A |
| MaxCyte, Inc. (MXCT)vs › | $114.62M | 0.09% | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $120.24M | 0.01% | N/A | N/A | N/A |
| Lucid Diagnostics Inc. (LUCD)vs › | $112.52M | 0.64% | N/A | N/A | N/A |
| Coya Therapeutics, Inc. (COYA)vs › | $112.36M | 0.00% | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $121.25M | 0.12% | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $110.73M | 0.07% | N/A | N/A | N/A |
Debt/Assets
8.9%
Debt/Equity
N/A
Current Ratio
2.00
Interest Coverage
-280.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 8.92% |
| 2026-03-31 | 7.59% |
| 2025-12-31 | 13.58% |
| 2025-09-30 | 7.12% |
| 2025-06-30 | 6.68% |
| 2025-03-31 | 5.76% |
| 2024-12-31 | 10.44% |
| 2024-09-30 | 5.68% |
| 2024-06-30 | 4.91% |
| 2024-03-31 | 4.70% |
| 2023-12-31 | 3.83% |
| 2023-09-30 | 3.77% |
| 2023-06-30 | 3.58% |
| 2023-03-31 | 4.02% |
| 2022-12-31 | 3.54% |
| 2022-09-30 | 2.39% |
| 2022-06-30 | 2.66% |
| 2022-03-31 | 4.08% |
| 2021-12-31 | 3.56% |
| 2021-09-30 | 4.17% |
| 2021-06-30 | 3.76% |
| 2021-03-31 | 6.30% |
| 2020-12-31 | 15.58% |
| 2020-09-30 | 14.63% |
| 2020-06-30 | 11.96% |
| 2020-03-31 | 10.98% |
| 2019-12-31 | 15.47% |
| 2019-09-30 | 4.50% |
| 2019-06-30 | 3.61% |
| 2019-03-31 | 4.08% |
| 2018-12-31 | 18.06% |
| 2018-09-30 | 15.76% |
| 2018-06-30 | 16.19% |
| 2018-03-31 | 14.37% |
| 2017-12-31 | 24.44% |
| 2017-09-30 | 18.25% |
| 2017-06-30 | 24.24% |
| 2017-03-31 | 17.06% |
| 2016-12-31 | 3.54% |
| 2016-09-30 | 2.28% |
| 2016-06-30 | 5.62% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 23.08% |
| 2015-06-30 | 40.34% |
| 2014-12-31 | 92.65% |
